These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3336351)

  • 1. The biooxidation of cytotoxic ellipticine derivatives: a key to structure-activity relationship studies?
    Meunier G; De Montauzon D; Bernadou J; Grassy G; Bonnafous M; Cros S; Meunier B
    Mol Pharmacol; 1988 Jan; 33(1):93-102. PubMed ID: 3336351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the 6-alkyl substitution of ellipticine on the uptake by NIH-3T3 cells and on the cytotoxicity.
    Deprés JP; Larue L; Paoletti J; Gouyette A
    Anticancer Res; 1988; 8(1):191-6. PubMed ID: 3358635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
    Auclair C; Paoletti C
    J Med Chem; 1981 Mar; 24(3):289-95. PubMed ID: 7265115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxidase-catalysed oxidation of N2,N6-dimethyl-9-hydroxyellipticinium acetate. Evidence for the formation of an electrophilic quinone-iminium derivative.
    Meunier G; Bernadou J; Meunier B
    Biochem Pharmacol; 1987 Aug; 36(16):2599-604. PubMed ID: 3606658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sanguinarine and ellipticine cytotoxic alkaloids isolated from well-known antitumor plants. Intracellular targets of their action].
    Faddeeva MD; Beliaeva TN
    Tsitologiia; 1997; 39(2-3):181-208. PubMed ID: 9312909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metabolism and pharmacokinetics of methoxy-9-ellipticine and its principal metabolite, hydroxy-9-ellipticine].
    Lecointe P; Puget A
    C R Seances Acad Sci III; 1983; 296(6):279-82. PubMed ID: 6405990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for electrophilic properties of N2-methyl-9-hydroxy ellipticinium acetate (Celiptium) from human biliary metabolites.
    Bernadou J; Monsarrat B; Roche H; Armand JP; Paoletti C; Meunier B
    Cancer Chemother Pharmacol; 1985; 15(1):63-5. PubMed ID: 4006051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidation pattern of the anticancer drug ellipticine by hepatic microsomes - similarity between human and rat systems.
    Stiborová M; Borek-Dohalská L; Aimová D; Kotrbová V; Kukacková K; Janouchová K; Rupertová M; Ryslavá H; Hudecek J; Frei E
    Gen Physiol Biophys; 2006 Sep; 25(3):245-61. PubMed ID: 17197724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ellipticine, 9-hydroxyellipticine, and 9-hydroxyellipiticinum: some biochemical properties of possible pharmacologic significance.
    Paoletti C; Auclair C; Lesca P; Tocanne JF; Malvy C; Pinto M
    Cancer Treat Rep; 1981; 65 Suppl 3():107-18. PubMed ID: 7049365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective binding of elliptinium acetate onto the 3'-terminal ribose of diribonucleosides monophosphates.
    Pratviel G; Bernadou J; Paoletti C; Meunier B; Gillet B; Guittet E; Lallemand JY
    Biochem Biophys Res Commun; 1985 May; 128(3):1173-9. PubMed ID: 2408615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships in a series of newly synthesized 1-amino-substituted ellipticine derivatives.
    Ducrocq C; Wendling F; Tourbez-Perrin M; Rivalle C; Tambourin P; Pochon F; Bisagni E; Chermann JC
    J Med Chem; 1980 Nov; 23(11):1212-6. PubMed ID: 7452670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian peroxidases activate anticancer drug ellipticine to intermediates forming deoxyguanosine adducts in DNA identical to those found in vivo and generated from 12-hydroxyellipticine and 13-hydroxyellipticine.
    Stiborová M; Poljaková J; Ryslavá H; Dracínský M; Eckschlager T; Frei E
    Int J Cancer; 2007 Jan; 120(2):243-51. PubMed ID: 17066455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new series of ellipticine derivatives (1-(alkylamino)-9-methoxyellipticine). Synthesis, DNA binding, and biological properties.
    Larue L; Rivalle C; Muzard G; Paoletti C; Bisagni E; Paoletti J
    J Med Chem; 1988 Oct; 31(10):1951-6. PubMed ID: 3172128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxidase-catalyzed O-demethylation reactions. Quinone-imine formation from 9-methoxyellipticine derivatives.
    Meunier G; Meunier B
    J Biol Chem; 1985 Sep; 260(19):10576-82. PubMed ID: 4030757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450- and peroxidase-mediated oxidation of anticancer alkaloid ellipticine dictates its anti-tumor efficiency.
    Stiborová M; Rupertová M; Frei E
    Biochim Biophys Acta; 2011 Jan; 1814(1):175-85. PubMed ID: 20576524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxidase-catalysed covalent binding of the antitumor drug 2N-methyl-9-hydroxy-ellipticine to proteins.
    Auclair C; Meunier B; Paoletti C
    Biochem Pharmacol; 1983 Dec; 32(24):3883-6. PubMed ID: 6661265
    [No Abstract]   [Full Text] [Related]  

  • 17. Redox parameters associated to cytotoxic and antitumor activities in the series of antitumor drugs ellipticines and derivatives.
    Auclair C
    Adv Exp Med Biol; 1990; 264():317-22. PubMed ID: 2244509
    [No Abstract]   [Full Text] [Related]  

  • 18. [Demonstration of an oxidative biotransformation of 9-methoxyellipticine. Comparison with the case of 9-hydroxyellipticine].
    Braham Y; Meunier G; Meunier B
    C R Acad Sci III; 1987; 304(11):301-6. PubMed ID: 3103875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between ellipticine derivatives and circular supercoiled DNA as revealed by gel electrophoresis. Possible relationship with the mechanisms of cytotoxicity .
    Malvy C; Cros S
    Biochem Pharmacol; 1986 Jul; 35(13):2264-7. PubMed ID: 3729982
    [No Abstract]   [Full Text] [Related]  

  • 20. [Syntheses designed to produce 8-amino ellipticine. Synthesis and pharmacological properties of 8-nitro ellipticine].
    Gansser C; Lévque X; Plat M; Viel C
    Farmaco Sci; 1982 May; 37(5):283-97. PubMed ID: 7095141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.